The Impact of Interferon Lambda 3 Gene Polymorphism on Natural Course and Treatment of Hepatitis C

被引:25
作者
Bellanti, F. [1 ]
Vendemiale, G. [1 ,2 ]
Altomare, E. [1 ]
Serviddio, G. [1 ]
机构
[1] Univ Foggia, CURE Ctr Liver Dis Res & Treatment, Dept Med & Occupat Sci, Foggia, Italy
[2] IRCCS Casa Sollievo Sofferenza, Foggia, Italy
来源
CLINICAL & DEVELOPMENTAL IMMUNOLOGY | 2012年
关键词
SINGLE NUCLEOTIDE POLYMORPHISMS; SUSTAINED VIROLOGICAL RESPONSE; IL28B GENOTYPE; PLUS RIBAVIRIN; SPONTANEOUS CLEARANCE; VIRAL KINETICS; IFN-LAMBDA; DIFFERENTIAL EXPRESSION; VIRUS-REPLICATION; INFECTED PATIENTS;
D O I
10.1155/2012/849373
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Host genetic factors may predict the outcome and treatment response in hepatitis C virus (HCV) infection. Very recently, three landmark genome-wide association studies identified single nucleotide polymorphisms near the interleukin 28B (IL28B) region which were more frequent in responders to treatment. IL28B encodes interferon (IFN)lambda 3, a type III IFN involved in host antiviral immunity. Favourable variants of the two most widely studied IL28B polymorphisms, rs12979860 and rs8099917, are strong pretreatment predictors of early viral clearance and sustained viral response in patients with genotype 1 HCV infection. Further investigations have implicated IL28B in the development of chronic HCV infection versus spontaneous resolution of acute infection and suggest that IL28B may be a key factor involved in host immunity against HCV. This paper presents an overview about the biological activity and clinical applications of IL28B, summarizing the available data on its impact on HCV infection. Moreover, the potential usefulness of IFN. in the treatment and natural history of this disease is also discussed.
引用
收藏
页数:9
相关论文
共 89 条
[1]   Genotype rs8099917 near the IL28B gene and amino acid substitution at position 70 in the core region of the hepatitis C virus are determinants of serum apolipoprotein B-100 concentration in chronic hepatitis C [J].
Aizawa, Yoshio ;
Yohizawa, Kai ;
Aida, Yuta ;
Ishiguro, Haruya ;
Abe, Hiroshi ;
Tsubota, Akihito .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2012, 360 (1-2) :9-14
[2]   Amino Acid Substitution in Hepatitis C Virus Core Region and Genetic Variation Near the Interleukin 28B Gene Predict Viral Response to Telaprevir with Peginterferon and Ribavirin [J].
Akuta, Norio ;
Suzuki, Fumitaka ;
Hirakawa, Miharu ;
Kawamura, Yusuke ;
Yatsuji, Hiromi ;
Sezaki, Hitomi ;
Suzuki, Yoshiyuki ;
Hosaka, Tetsuya ;
Kobayashi, Masahiro ;
Kobayashi, Mariko ;
Saitoh, Satoshi ;
Arase, Yasuji ;
Ikeda, Kenji ;
Chayama, Kazuaki ;
Nakamura, Yusuke ;
Kumada, Hiromitsu .
HEPATOLOGY, 2010, 52 (02) :421-429
[3]   Review article: chronic hepatitis C - natural history and cofactors [J].
Alberti, A ;
Vario, A ;
Ferrari, A ;
Pistis, R .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 :74-78
[4]   Lambda interferon (IFN-λ), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo [J].
Ank, N ;
West, H ;
Bartholdy, C ;
Eriksson, K ;
Thomsen, AR ;
Paludan, SR .
JOURNAL OF VIROLOGY, 2006, 80 (09) :4501-4509
[5]   IL28B SNP rs8099917 Is Strongly Associated with Pegylated Interferon-α and Ribavirin Therapy Treatment Failure in HCV/HIV-1 Coinfected Patients [J].
Aparicio, Ester ;
Parera, Mariona ;
Franco, Sandra ;
Perez-Alvarez, Nuria ;
Tural, Cristina ;
Clotet, Bonaventura ;
Angel Martinez, Miguel .
PLOS ONE, 2010, 5 (10)
[6]   Association between IL28B polymorphisms and first-phase viral load decrease in chronic hepatitis C virus-infected patients treated with peginterferon alfa-2b/ribavirin [J].
Arends, Joop E. ;
Fransen, Justin H. ;
Hoepelman, Andy I. M. ;
van Baarle, Debbie .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 38 (06) :538-539
[7]   IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C [J].
Asselah, Tarik ;
De Muynck, Simon ;
Broet, Philippe ;
Masliah-Planchon, Julien ;
Blanluet, Maud ;
Bieche, Ivan ;
Lapalus, Martine ;
Martinot-Peignoux, Michelle ;
Lada, Olivier ;
Estrabaud, Emilie ;
Zhang, Qian ;
El Ray, Ahmed ;
Vidaud, Dominique ;
Ripault, Marie-Pierre ;
Boyer, Nathalie ;
Bedossa, Pierre ;
Valla, Dominique ;
Vidaud, Michel ;
Marcellin, Patrick .
JOURNAL OF HEPATOLOGY, 2012, 56 (03) :527-532
[8]   Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection [J].
Bacon, Bruce R. ;
Gordon, Stuart C. ;
Lawitz, Eric ;
Marcellin, Patrick ;
Vierling, John M. ;
Zeuzem, Stefan ;
Poordad, Fred ;
Goodman, Zachary D. ;
Sings, Heather L. ;
Poordad, Fred ;
Goodman, Zachary D. ;
Sings, Heather L. ;
Boparai, Navdeep ;
Burroughs, Margaret ;
Brass, Clifford A. ;
Albrecht, Janice K. ;
Esteban, Rafael .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (13) :1207-1217
[9]   Serum Level of IP-10 Increases Predictive Value of IL28B Polymorphisms for Spontaneous Clearance of Acute HCV Infection [J].
Beinhardt, Sandra ;
Aberle, Judith H. ;
Strasser, Michael ;
Dulic-Lakovic, Emina ;
Maieron, Andreas ;
Kreil, Anna ;
Rutter, Karoline ;
Staettermayer, Albert F. ;
Datz, Christian ;
Scherzer, Thomas M. ;
Strassl, Robert ;
Bischof, Martin ;
Stauber, Rudolf ;
Bodlaj, Gerd ;
Laferl, Hermann ;
Holzmann, Heidemarie ;
Steindl-Munda, Petra ;
Ferenci, Peter ;
Hofer, Harald .
GASTROENTEROLOGY, 2012, 142 (01) :78-U219
[10]   IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes [J].
Bochud, Pierre-Yves ;
Bibert, Stephanie ;
Kutalik, Zoltan ;
Patin, Etienne ;
Guergnon, Julien ;
Nalpas, Bertrand ;
Goossens, Nicolas ;
Kuske, Lorenz ;
Muellhaupt, Beat ;
Gerlach, Tillman ;
Heim, Markus H. ;
Moradpour, Darius ;
Cerny, Andreas ;
Malinverni, Raffaele ;
Regenass, Stephan ;
Dollenmaier, Guenter ;
Hirsch, Hans ;
Martinetti, Gladys ;
Gorgiewski, Meri ;
Bourliere, Marc ;
Poynard, Thierry ;
Theodorou, Ioannis ;
Abel, Laurent ;
Pol, Stanislas ;
Dufour, Jean-Francois ;
Negro, Francesco .
HEPATOLOGY, 2012, 55 (02) :384-394